Guardant HealthGH stock rocketed Thursday on an impressive beat-and-raise earnings report that included 40% volume growth from its oncology division. That 40% volume growth for oncology tests was a ...
Artificial intelligence leader OusterOUST has rebounded from a critical support level in recent weeks, a move by the stock ahead of a third-quarter earnings report due next week. That makes Ouster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results